Press Room

Healthtech Startup Mesh Bio Raises US$1.8 Million in Seed Funding
March 10, 2021

Singapore-based healthtech startup Mesh Bio has raised USD1.8 million (SGD2.4 million) in Seed funding, led by deep tech investors Elev8.vc and Enterprise Singapore’s investment arm Seeds Capital, along with Citrine Capital and Tael Partners. The funds will be used to accelerate the rollout of Mesh Bio’s solution, DARA® – a predictive analytics and clinical workflow automation solution for healthcare providers – in Southeast Asia and Hong Kong. The funding will also support clinical partnerships and collaborations.

Read more
arrow_forward
Mesh Bio Becomes the First Asian Start-Up to Join Startup Creasphere
November 19, 2019

Mesh Bio, a Singapore-based predictive analytics digital health startup for diagnosis and management of chronic diseases, has announced today their participation in the upcoming Startup Creasphere Batch 3 accelerator program, an international collaboration set to pilot Mesh Bio’s digital solutions.

Read more
arrow_forward